CN103169904B - Traditional Chinese medicine composition for treating lung cancer - Google Patents
Traditional Chinese medicine composition for treating lung cancer Download PDFInfo
- Publication number
- CN103169904B CN103169904B CN201310059866.5A CN201310059866A CN103169904B CN 103169904 B CN103169904 B CN 103169904B CN 201310059866 A CN201310059866 A CN 201310059866A CN 103169904 B CN103169904 B CN 103169904B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating lung cancer. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10-40 parts of cordate houttuynia, 5-15 parts of Sichuan fritillary bulb, 5-15 parts of scutellaria root, 5-25 parts of mulberry bark, 5-15 parts of almond, 5-25 parts of radix stemonae, 5-25 parts of coltsfoot flower, 5-15 parts of balloonflower root, 5-15 parts of swallowwort rhizome, 5-15 parts of pinellia tuber, 10-40 parts of barbat skullcap, 5-15 parts of licorice root, 10-40 parts of hedyotis diffusa, 5-25 parts of honeysuckle, 10-40 parts of pearl barley and 5-15 parts of dried tangerine peel. The traditional Chinese medicine composition disclosed by the invention has the effects of heat clearing, detoxifying, lung moistening, qi descending, spleen invigorating, phlegm removing, swelling reducing and stasis removing; and during lung cancer treatment, the curative effect is remarkable, and the role is reliable. The traditional Chinese medicine composition disclosed by the invention has the advantages of wide ingredient drug source, simplicity and convenience in preparation, mild medicine property and no toxic and side effects.
Description
Technical field
The present invention relates to a kind of not pharmaceutical product of definite structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of pulmonary carcinoma.
Background technology
Pulmonary carcinoma is a kind of common lung primary malignant tumor, and large absolutely number pulmonary carcinoma originates from bronchial mucosa epithelium, therefore also claim lung bronchogenic carcinoma, its mortality rate is very high.Along with industrial construction is fast-developing, people's living environment is subject to serious impact, adds the bad life habits such as smoking, and countries in the world are industrially developed country particularly, lung cancer morbidity rate and case fatality rate are in rapid rising, and lung cancer mortality has occupied first of various cancer mortalities.Pulmonary carcinoma makes on the one hand bronchial wall extend expansion in growth course, and is invaded and be close to lung tissue and form lump by bronchial wall, invades simultaneously and in bronchus, causes its luminal stenosis or obstruction.This cancer further can be invaded the contiguous organ pipe tissue such as thoracic wall, mediastinum, heart, trunk from lung direct extension; Through lymphatic channel Blood route metastasis to other positions of health.The method for the treatment of pulmonary carcinoma has operation, radiotherapy, chemotherapy and Drug therapy etc. at present.Although can play to a certain extent the effect of controlling pulmonary carcinoma progress, the toxicity that Radiotherapy chemotherapy brings is also very obvious, patient is usually agonizing.
For patients with lung cancer, adopting traditional Chinese medicine therapy for treatment is good method, to extend the survival of patients time, improves cancer patient's quality of life simultaneously.
The traditional Chinese medical science thinks, pulmonary carcinoma belongs to the categories such as the traditional Chinese medical science " lump in the right hypochondrium ", " cough ", " spitting of blood ", " chest pain ".The cause of disease of pulmonary carcinoma is the exopathogen such as poison heresy, phlegm-damp, pyretic toxicity, seizes the opportunity in body deficiency of vital QI and the criminal's of invading lung, and heresy is amassed in the heart, then forms shape and has piece.Therefore suitable heat clearing away eliminating stagnation, moistening lung qi-benefitting, invigorating the spleen for dissipating phlegm.
Summary of the invention
In order to overcome in prior art operation, radiation and chemotherapy easily damages human body and the deficiency of weak curative effect, the invention provides a kind of prepare easy, cost is low, curative effect is reliable, the Chinese medicine composition of the treatment pulmonary carcinoma that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of pulmonary carcinoma, is characterized in that: its raw material of Chinese medicine by following weight portion forms: Herba Houttuyniae 10-40 part, Bulbus Fritillariae Cirrhosae 5-15 part, Radix Scutellariae 5-15 part, Cortex Mori 5-25 part, Semen Armeniacae Amarum 5-15 part, Radix Stemonae 5-25 part, Flos Farfarae 5-25 part, Radix Platycodonis 5-15 part, Rhizoma Cynanchi Stauntonii 5-15 part, Rhizoma Pinelliae 5-15 part, Herba Scutellariae Barbatae 10-40 part, Radix Glycyrrhizae 5-15 part, Hedyotidis Diffusae 10-40 part, Flos Lonicerae 5-25 part, Semen Coicis 10-40 part, Pericarpium Citri Reticulatae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of pulmonary carcinoma, is characterized in that: its raw material of Chinese medicine by following weight portion forms: 30 parts of Herba Houttuyniae, 10 parts of Bulbus Fritillariae Cirrhosaes, 10 parts of Radix Scutellariaes, 15 parts of Cortex Mori, 10 parts, Semen Armeniacae Amarum, 15 parts of the Radixs Stemonae, 15 parts of Flos Farfaraees, 10 parts of Radix Platycodoniss, 10 parts of Rhizoma Cynanchi Stauntoniis, 10 parts of the Rhizoma Pinelliaes, 30 parts of Herba Scutellariae Barbataes, 10 parts, Radix Glycyrrhizae, 30 parts of Hedyotidis Diffusaes, 15 parts of Flos Loniceraes, 30 parts of Semen Coiciss, 10 parts of Pericarpium Citri Reticulataes.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: Herba Houttuyniae has the effect of heat-clearing and toxic substances removing, removing pus and relieving carbuncle, inducing diuresis for treating stranguria syndrome; Bulbus Fritillariae Cirrhosae has clearing heat and moistening lung, the effect of preventing phlegm from forming and stopping coughing; Radix Scutellariae has the effect of heat clearing and damp drying, eliminating fire and detoxication, arresting bleeding and miscarriage prevention; Cortex Mori has the effect of eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema; The effect that Semen Armeniacae Amarum has expelling phlegm for arresting cough, numbness is opened in the intestine moistening of relievining asthma, the therapeutic method to keep the adverse QI flowing downwards; The Radix Stemonae has the effect of lung moistening, the therapeutic method to keep the adverse QI flowing downwards, cough-relieving; Flos Farfarae has nourishing the lung to keep the adverse QI downward, the effect of the antitussive that reduces phlegm; Radix Platycodonis has lung qi dispersing and eliminates the phlegm, fosters the spirit of nobility and enrich blood, sharp the five internal organs, mend the effect of five kinds of over strain; Rhizoma Cynanchi Stauntonii has the effect of lowering the adverse-rising QI to resolve phlegm, eliminating the pathogens from the lung cough-relieving; The Rhizoma Pinelliae has the effect of drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Herba Scutellariae Barbatae has the effect of heat-clearing and toxic substances removing, dissipating blood stasis hemostasis, subduing swelling and relieving pain; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription; Hedyotidis Diffusae has the effect of heat-clearing and toxic substances removing, diuresis of blood circulation promoting; Flos Lonicerae has the effect of heat-clearing and toxic substances removing; Semen Coicis has that inducing diuresis to remove edema, spleen invigorating dry, the effect of arthralgia relieving by relaxing muscles and tendons, clearing away heat and discharging pus; Pericarpium Citri Reticulatae has the effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune.The selected medicament composing prescription of the present invention; its drug component is through dialectical compatibility; complement each other using, there is synergism, play altogether the effect of heat-clearing and toxic substances removing, nourishing the lung to keep the adverse QI downward, invigorating the spleen for dissipating phlegm, dispersing swelling and dissipating binds; improve body immunity; the normal function of protection body, plays attenuation synergistic to the treatment of pulmonary carcinoma, improves patients clinical symptom; extend the survival of patients time, improve life in patients.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 80%.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Herba Houttuyniae 30g, Bulbus Fritillariae Cirrhosae 10g, Radix Scutellariae 10g, Cortex Mori 15g, Semen Armeniacae Amarum 10g, Radix Stemonae 15g, Flos Farfarae 15g, Radix Platycodonis 10g, Rhizoma Cynanchi Stauntonii 10g, Rhizoma Pinelliae 10g, Herba Scutellariae Barbatae 30g, Radix Glycyrrhizae 10g, Hedyotidis Diffusae 30g, Flos Lonicerae 15g, Semen Coicis 30g, Pericarpium Citri Reticulatae 10g.
Embodiment 2
Treat a Chinese medicine composition for pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Herba Houttuyniae 40g, Bulbus Fritillariae Cirrhosae 12g, Radix Scutellariae 5g, Cortex Mori 10g, Semen Armeniacae Amarum 8g, Radix Stemonae 25g, Flos Farfarae 10g, Radix Platycodonis 5g, Rhizoma Cynanchi Stauntonii 12g, Rhizoma Pinelliae 8g, Herba Scutellariae Barbatae 20g, Radix Glycyrrhizae 15g, Hedyotidis Diffusae 10g, Flos Lonicerae 25g, Semen Coicis 10g, Pericarpium Citri Reticulatae 8g.
Embodiment 3
Treat a Chinese medicine composition for pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Herba Houttuyniae 20g, Bulbus Fritillariae Cirrhosae 5g, Radix Scutellariae 15g, Cortex Mori 20g, Semen Armeniacae Amarum 12g, Radix Stemonae 10g, Flos Farfarae 5g, Radix Platycodonis 8g, Rhizoma Cynanchi Stauntonii 15g, Rhizoma Pinelliae 12g, Herba Scutellariae Barbatae 10g, Radix Glycyrrhizae 12g, Hedyotidis Diffusae 25g, Flos Lonicerae 10g, Semen Coicis 40g, Pericarpium Citri Reticulatae 5g.
Embodiment 4
Treat a Chinese medicine composition for pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Herba Houttuyniae 10g, Bulbus Fritillariae Cirrhosae 15g, Radix Scutellariae 8g, Cortex Mori 25g, Semen Armeniacae Amarum 5g, Radix Stemonae 20g, Flos Farfarae 25g, Radix Platycodonis 12g, Rhizoma Cynanchi Stauntonii 5g, Rhizoma Pinelliae 15g, Herba Scutellariae Barbatae 25g, Radix Glycyrrhizae 5g, Hedyotidis Diffusae 40g, Flos Lonicerae 20g, Semen Coicis 20g, Pericarpium Citri Reticulatae 12g.
Embodiment 5
Treat a Chinese medicine composition for pulmonary carcinoma, its raw material of Chinese medicine by following weight proportion forms: Herba Houttuyniae 25g, Bulbus Fritillariae Cirrhosae 8g, Radix Scutellariae 12g, Cortex Mori 5g, Semen Armeniacae Amarum 15g, Radix Stemonae 5g, Flos Farfarae 20g, Radix Platycodonis 15g, Rhizoma Cynanchi Stauntonii 8g, Rhizoma Pinelliae 5g, Herba Scutellariae Barbatae 40g, Radix Glycyrrhizae 8g, Hedyotidis Diffusae 20g, Flos Lonicerae 5g, Semen Coicis 25g, Pericarpium Citri Reticulatae 15g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soak 15～20 minutes, then add water and do not have approximately 8 centimetres of powder, decoct.At a simmer, adopt intense fire to decoct, after boiling, use slow fire boiling 20～30 minutes; Second decocts, and adds water and does not have approximately 6 centimetres of powder, decocts, and after water boils, decocts 15～20 minutes.Decoct extracting juice twice, merge.
Treat a Chinese medicine composition for pulmonary carcinoma, clinical efficacy is summed up:
One, general data:
This Chinese medicine composition is applied to clinical observation case 50 examples, 35～65 years old age.
two,diagnostic point
1, choking of occurring in the recent period coughed and continued several weeks and do not heal, the expectorant of repeatedly spitting blood, or the obstructive pneumonia of outbreak repeatedly, or without the explainable pulmonary atelectasis of other reasons;
2, clinical visible cough, has disease, sputum mixed with blood, chest pain, heating; And can find pulmonary abscess, pleuritis etc.; Supraclavicular lymph nodes enlargement or the enlargement of other superficial lymphs knot;
X-ray checks: hilus pulumonis portion occurs that one-sided shade increases as seen, or pulmonary has orphan's circle or nodositas to infiltrate focus.Can there be the x-ray signs such as obstructive pneumonia, pulmonary atelectasis, hilus pulumonis and widened mediastinum, hydrothorax, pericardial effusion and diaphragmatic paralysis;
CT examination: can show on rabat the easily overlapping region of anatomy, can find the swollen thing at the dissatisfied position of x-ray chest films showed, can determine tumor infringement scope in mediastinum, lymphatic metastasis situation.
Three, usage and dosage:
During clinical practice, the amounts of components in compositions is taken the circumstances into consideration increase and decrease according to patient's body weight and age.Potion on the one, the about 300ml of twice extracting juice of decocting, minute morning, evening take for twice.It within 30 days, is a course for the treatment of.
Four, criterion of therapeutical effect:
(1) effective: symptom is alleviated completely or disappeared, reach life cycle more than 3 years;
(2) effective: symptom partial rcsponse, life cycle is more than 1 year;
(3) invalid; Symptom is without any improvement, has the trend of deterioration, even the short time is dead.
Five, therapeutic effect: in this clinical observation case, take medicine 3-10 the course for the treatment of, effective 25 examples, effective 15 examples, invalid 10 examples.During treatment, there is not toxic and side effects.
Six, model case:
Case 1:
Liu, man, 45 years old.Because of dry cough, become thin, " pulmonary carcinoma " is made a definite diagnosis through CT examination by hospital, chemotherapy 3 times, patient's nausea and vomiting, weak, spirit poor, stop chemotherapy.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, symptom obtains partial rcsponse, continues to take 6 courses for the treatment of, and foci disappearance is more than half, so far existence.
Case 2:
Chen, female, 52 years old.Because of cough, sputum streaked with blood 3 months, accompanies uncomfortable in chestly, breathes hard and is admitted to hospital, and through being CT, examines as left pulmonary carcinoma.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, symptom alleviates, and spirit is clearly better, and continues to take 3 courses for the treatment of, and pulmonary's cancer symptom partial rcsponse is survived 2 years.
Claims (1)
1. a Chinese medicine composition for the treatment of pulmonary carcinoma, is characterized in that: its raw material of Chinese medicine and weight proportion are: Herba Houttuyniae 30g, Bulbus Fritillariae Cirrhosae 10g, Radix Scutellariae 10g, Cortex Mori 15g, Semen Armeniacae Amarum 10g, Radix Stemonae 15g, Flos Farfarae 15g, Radix Platycodonis 10g, Rhizoma Cynanchi Stauntonii 10g, Rhizoma Pinelliae 10g, Herba Scutellariae Barbatae 30g, Radix Glycyrrhizae 10g, Hedyotidis Diffusae 30g, Flos Lonicerae 15g, Semen Coicis 30g, Pericarpium Citri Reticulatae 10g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310059866.5A CN103169904B (en) | 2013-02-26 | 2013-02-26 | Traditional Chinese medicine composition for treating lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310059866.5A CN103169904B (en) | 2013-02-26 | 2013-02-26 | Traditional Chinese medicine composition for treating lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103169904A CN103169904A (en) | 2013-06-26 |
| CN103169904B true CN103169904B (en) | 2014-08-20 |
Family
ID=48630391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310059866.5A Expired - Fee Related CN103169904B (en) | 2013-02-26 | 2013-02-26 | Traditional Chinese medicine composition for treating lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103169904B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104001080A (en) * | 2014-05-23 | 2014-08-27 | 邬红霞 | Traditional Chinese medicine composition for treating lung cancer and preparation method thereof |
| CN104383390A (en) * | 2014-10-30 | 2015-03-04 | 宿州学院 | Chinese traditional medicine preparation for treating lung cancer |
| CN105920502A (en) * | 2016-06-29 | 2016-09-07 | 贵州中草医医院 | Traditional Chinese medicinal composition for treating lung cancer |
| CN106075028A (en) * | 2016-07-22 | 2016-11-09 | 董维礼 | A kind of Chinese medicinal capsule curing lung tumor |
| CN108938962A (en) * | 2018-10-25 | 2018-12-07 | 林洪生 | A kind of Chinese medicine composition and preparation method preventing Lung Cancer Recurrence and transfer |
| CN109481609A (en) * | 2018-12-31 | 2019-03-19 | 肖丽丽 | It is a kind of for treating the Chinese medicine composition and preparation method of syndrome of intermin-gled phlegm and blood stasis lung cancer |
| CN114796388A (en) * | 2022-04-16 | 2022-07-29 | 赵浚宏 | A Chinese medicinal composition for treating lung cancer, and its preparation method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101357202A (en) * | 2008-09-02 | 2009-02-04 | 李天基 | Chinese traditional medicine for treating hepatosis and preparation method thereof |
| CN101703726B (en) * | 2009-11-19 | 2010-09-08 | 何玉伟 | Medicament for treating lung cancer |
| CN101869678B (en) * | 2010-06-29 | 2011-09-21 | 马学荣 | Medicament for treating bronchitis cough |
-
2013
- 2013-02-26 CN CN201310059866.5A patent/CN103169904B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103169904A (en) | 2013-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103169904B (en) | Traditional Chinese medicine composition for treating lung cancer | |
| CN105012392A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN107050338A (en) | Chinese medicine composition and preparation method for treating chronic pharyngitis | |
| CN103536858B (en) | Medicine for treating rheumatoid arthritis | |
| CN102872381B (en) | Traditional Chinese medicine composition for treating epidemic parotitis | |
| CN104758890A (en) | Traditional Chinese medicine composition for treating cough | |
| CN103330826B (en) | Traditional Chinese medicine composition for treating deficiency of lung yin | |
| CN105497486A (en) | Traditional Chinese medicine composition for treating chronic rhinitis | |
| CN103211970B (en) | Traditional Chinese medicine composition for treatment of wind-heat cough | |
| CN102949553B (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN104840855A (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis | |
| CN104491825B (en) | A kind of Chinese medicine ointment for the treatment of oral ulcer | |
| CN106075265A (en) | The Chinese medicine composition for the treatment of viral influenza | |
| CN104998074A (en) | Traditional Chinese medicine for treating gastropathy and preparation method thereof | |
| CN104922434A (en) | Decoction medicine for treating polyp of vocal cord and preparation method thereof | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN102552772B (en) | Traditional Chinese medicine used for treating chronic cough lung deficiency | |
| CN106177561A (en) | One treats phthisical Chinese medicine composition | |
| CN104474286A (en) | Traditional Chinese medicine composite for treating dry-heat lung impairing type chronic bronchitis | |
| CN104887874A (en) | Traditional Chinese medicine composition for treating pneumonia | |
| CN105147845A (en) | Traditional Chinese medicine for treating stomach fire toothache | |
| CN104491391A (en) | Traditional Chinese medicine composition for treating pharyngitis | |
| CN104257833A (en) | Traditional Chinese medical composition for treating gout | |
| CN104257875A (en) | Externally-applied traditional Chinese medicine composition for nursing acute mastitis of women | |
| CN104189513A (en) | Lymphatic tuberculosis regulating qi-flowing and reducing edema preparation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: TANG HUASHU Free format text: FORMER OWNER: SUN SHENGBO Effective date: 20140708 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Tang Huashu Inventor after: Sun Shengbo Inventor before: Sun Shengbo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN SHENGBO TO: TANG HUASHU SUN SHENGBO |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140708 Address after: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101 Applicant after: Tang Huashu Address before: 264300 Rongcheng City, Shandong Province Cultural East Road, No. 20, No. Applicant before: Sun Shengbo |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140820 Termination date: 20150226 |
|
| EXPY | Termination of patent right or utility model |